Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Drugs in Context|June 6, 2020
Pharmacologicaltreatment of COVID-19: lights and shadowsFrancesco Menzella, Mirella Biava, Chiara Barbieri, et al.
Drugs in Context|December 12, 2018
Severe refractory asthma: current treatment options and ongoing researchFrancesco Menzella, Francesca Bertolini, Mirella Biava, et al.
Drugs in Context|April 27, 2019
Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?Francesco Menzella, Mirella Biava, Diego Bagnasco, et al.
Multidisciplinary Respiratory Medicine|December 7, 2020
COVID-19: general overview, pharmacological options and ventilatory support strategiesFrancesco Menzella, Andrea Matucci, Alessandra Vultaggio, et al.
Frontiers in Pediatrics|April 18, 2022
Non-bullous Impetigo: Incidence, Prevalence, and Treatment in the Pediatric Primary Care Setting in ItalyElisa Barbieri, Gloria Porcu, Daniele Dona', et al.
Viral Immunology|October 25, 2014
Murine granulocyte-macrophage colony-stimulating factor expressed from a bicistronic simian immunodeficiency virus-based integrase-defective lentiviral vector does not enhance T-cell responses in miceZuleika Michelini, Donatella Negri, Mirella Biava, et al.
Frontiers in Microbiology|March 30, 2022
<i>In vitro</i> Evaluation of Antiviral Efficacy of a Standardized Hydroalcoholic Extract of Poplar Type Propolis Against SARS-CoV-2Giuseppe Sberna, Marco Biagi, Giovanni Marafini, et al.
Viruses|April 26, 2019
Inflammatory and Humoral Immune Response during Ebola Virus Infection in Survivor and Fatal Cases Occurred in Sierra Leone during the 2014⁻2016 Outbreak in West AfricaFrancesca Colavita, Mirella Biava, Concetta Castilletti, et al.
Advances in Experimental Medicine and Biology|November 20, 2016
Enabling Rapid Response to the 2014-2016 Ebola Epidemic: The Experience and the Results of the National Institute for Infectious Diseases Lazzaro SpallanzaniEmanuele Nicastri, Concetta Castilletti, Mirella Biava, et al.
Mediators of Inflammation|July 4, 2018
ZIKV Infection Induces an Inflammatory Response but Fails to Activate Types I, II, and III IFN Response in Human PBMCFrancesca Colavita, Veronica Bordoni, Claudia Caglioti, et al.
Pageof 2